García ÁPJ, Morejón RL, Grasso LF, Aguilera MJ, Reyes MY

Language: Spanish
References: 16
Page: 1165-1176
PDF size: 927.78 Kb.

ABSTRACT

Introduction: COVID-19 is a disease in which mechanical ventilation acquires vital importance. It is estimated that 50 % of the serious and critical patients requiring management in intensive care units die.
Objectives: to assess the impact of the ventilation modes used in patients with COVID-19 in Lombardy, Italy, on oxygenation, hemodynamics and mortality.
Materials and methods: a retrospective, longitudinal, analytic study was carried out in 86 critical patients with COVID-19 who entered the Main Hospital of Crema, in Lombardy, Italy, from April 1st to May 20, 2020.
Results: the survival was 76.7 %. The used mode showed the same behavior in deceased patients (BiPAP-3, PCV-4, VCRP-4, APRV-5, VCV-4) and in alive patients (BiPAP-10, PCV-17, VCRP-14, APRV-15, VCV-10). X2 = 0.59. ANOVA test index PO2/FIO2 (PCV = 132), (BiPAP = 132) (VCV=115) p = 0.924. PEEP (BiPAP-12, PCV-13, VCRP-13, APRV-13, VCV-14) p = 0.205. PCO2 (BiPAP-55, PCV-52, VCRP-57, APRV-59, VCV-57) p = 0.512. Average blood pressure (BiPAP-84, PCV-83, VCRP-84, APRV-82, VCV-83) p = 0.988. PEEP models according to ventilation mode: BiPAP: PEEP = -0.0331 (PO2/FiO2 index) +18.215. PCV: PEEP = -0.0047 (PO2/FiO2 index) + 13.717; VCRP: PEEP = -0.0204 (PO2/FiO2 index) + 15.678; APRV: PEEP = -0.0092 (PO2/FiO2 index) +14.889.
Conclusion: the evolution of the critical patient with COVID-19 is determined mostly by the invasive mechanical ventilation; but we did not find evidence enough to recommend one or the other ventilation mode. The success stands in knowing accurately the characteristics of the ventilator, the ventilation modes and the patient.

REFERENCES

1. Li X, Xu S, Yu M, et al. Risk factors for severity and mortality in adult COVID-19 in patients in Wuhan. J Allergy Clin Immunol. 2020 Jul;146(1):110-8. Citado en PubMed; PMID: 32294485.

2. Sangrador OC, Garmendia Leiza JR, Pérez Boillos MJ, et al. Impacto de la COVID-19 en la mortalidad de la comunidad autónoma de Castilla y León. Gac Sanit. 2020 May. Citado en PubMed; PMID: 32446595.

3. Sánchez-Álvarez J, Pérez Fontán M, Jiménez Martín C, et al. Situación de la infección por SARS-CoV-2 en pacientes en tratamiento renal sustitutivo. Informe del Registro COVID-19 de la Sociedad Española de Nefrología. Nefrología [Internet]. 2020 [citado 14/06/2020];40(3):272-8. Disponible en: Disponible en: https://www.sciencedirect.com/science/article/pii/S0211699520300400

4. Pallarés Carratalá V, Górriz-Zambrano C. Morillas Ariño C, et al. COVID-19 y enfermedad cardiovascular y renal: ¿Dónde estamos? ¿Hacia dónde vamos? Medicina de Familia. Semergen [Internet]. 2020 [citado 23/06/2020];46(1):78-87. Disponible en: Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S1138359320301441?via%3Dihub

5. Price S, Singh S, Ledot S, et al. Respiratory management in severe acute respiratory syndrome coronavirus 2 infection. Eur Heart J Acute Cardiovasc Care. 2020;9(3):229-38. Citado en PubMed; PMID: 32375488.

6. Medeiros Figueiredo A, Daponte-Codina A, Moreira Marculino D, et al. Factores asociados a la incidencia y la mortalidad por COVID-19 en las comunidades autónomas. Gac Sanit [Internet]. 2020 [citado 28/06/2020]. Disponible en: Disponible en: https://www.sciencedirect.com/science/article/pii/S0213911120301242?via%3Dihub

7. Rodríguez Y, Novelli L, Rojas M, et al. Autoinflammatory and autoimmune conditions at the crossroad of COVID-19. J of Autoimmunity [Internet]. 2020 Nov [citado 23/06/2020];114:102506. Disponible en: Disponible en: https://www.sciencedirect.com/science/article/pii/S0896841120301281

8. Cressoni M, Chiurazzi C, Chiumello C, et al. Does high PEEP prevent alveolar cycling? Med Klin Intensivmed Notfmed. 2018;113(Suppl 1):7-12. Citado en PubMed; PMID: 29134246.

9. Cabrera Galán C. Estudio randomizado de ventilación con presión binivel frente a presión positiva continua en pacientes con síndrome de obesidad-hipoventilación e insuficiencia respiratoria aguda [tesis en Internet]. Cádiz: Universidad de Cádiz; 2017 [citado 07/03/2018]. Disponible en: Disponible en: https://dialnet.unirioja.es/servlet/tesis?codigo=110202

10. Carter C, Osborn M, Agagah G, et al. COVID-19 disease: invasive ventilation. Clinics in Integrated Care. 2020 Jul;1:100004. Citado en PubMed; PMID: 7261657.

11. Victor S, Roberts S, Mitchell S, et al. Extubate Trial Group. Biphasic Positive Airway Pressure or Continuous Positive Airway Pressure: A Randomized Trial. Pediatrics [Internet]. 2016 Aug [citado 10/07/2020];138(2):e20154095. DOI: 10.1542/peds.2015-4095.

12. Zeng F, Huang Y, Guo Y, et al. Association of inflammatory markers with the severity of COVID-19: A meta-analysis. Int J Infect Dis. 2020 Jul;96:467-74. Citado en PubMed; PMID: 32425643.

13. Kacmarek R, Branson R. Should Intermittent Mandatory Ventilation Be Abolished? Respir Care. 2016 Jun;61(6):854-66. Citado en PubMed; PMID: 27235318.

14. Repessé X, Charron C, Geri G, et al. Impact of positive pressure ventilation on mean systemic filling pressure in critically ill patients afterdeath. J Appl Physiol. 2017;122(6):1373-8. Citado en PubMed; PMID: 2836012.

15. Coudroy R, Frat J, Boissier F, et al. The authors reply. Crit Care Med. 2018 Oct; 46(10):e1012. Citado en PubMed; PMID: 30216318.

16. Bittencourt H, Reis H, Lima M, et al. Non-Invasive Ventilation in Patients with Heart Failure: A Systematic Review and Meta-Analysis. Arq Bras Cardiol. 2017 Feb;108(2):161-8. Citado en PubMed; PMID: 28099587.